<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02024165</url>
  </required_header>
  <id_info>
    <org_study_id>OBM-WP-2013</org_study_id>
    <secondary_id>IRB</secondary_id>
    <nct_id>NCT02024165</nct_id>
  </id_info>
  <brief_title>Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability</brief_title>
  <acronym>FHR</acronym>
  <official_title>Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OBMedical Company</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OBMedical Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific goal of the proposed research is to develop a reliable, non-invasive fetal and
      maternal heart rate and contraction monitor that is unaffected by obesity and requires less
      nursing intervention than the tocodynamometer and Doppler ultrasound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The majority of obstetric deliveries in the US undergo electronic monitoring and continuous
      uterine activity and fetal heart rate (FHR) monitoring is the standard of care. Typically,
      external transducers are employed, the reliability of which depends on their proper
      positioning, which may be disturbed by patient or fetal movement. The tocodynamometer (strain
      gauge, toco for short) provides frequency and timing of contractions, but requires
      transmission of tension from the uterus to the sensor. Fetal heart rate is acquired with an
      external Doppler ultrasound transducer. The reliability of this monitor depends on the
      ability to obtain a window to the fetal heart.

      In some patients, particularly the obese, the toco and ultrasound may fail to monitor
      consistently. In others both transducers require frequent repositioning by the nursing staff,
      and the Doppler may erroneously report maternal heart rate instead of fetal.

      The alternative uterine activity monitor is an intrauterine pressure catheter (IUPC), which
      is placed through the cervical os in the adequately dilated patient with ruptured membranes.
      While this monitor usually provides a more reliable signal than the toco, as well as
      quantitative information regarding intrauterine pressure, it is invasive and there is an
      increased risk of infection. The alternative FHR monitor is via fetal scalp electrode (FSE),
      which is applied transvaginally to the fetal presenting part, also requiring adequate
      cervical dilation and ruptured membranes. While the FSE usually provides a more reliable
      signal, it is similarly invasive and increases risk of infection.

      Maternal obesity (defined as BMI at presentation â‰¥ 30) is an ever-increasing problem in the
      US, and is even more prominent in the obstetric suite. Meanwhile, obese women have an
      increased risk for labor problems, infections and other complications. Noninvasive labor
      monitoring, while preferable to reduce the infection risk, is particularly unreliable in this
      population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal Heart Rate Interpretability</measure>
    <time_frame>2 hours</time_frame>
    <description>The Fetal Heart Rate (or FHR) of the electrode sensor will be compared to the FHR of the ultrasound when both are compared to the FSE. Percentage of time that signals are interpretable will be compared between devices</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">71</enrollment>
  <condition>Laboring Women With Ultrasound and FSE Monitoring</condition>
  <arm_group>
    <arm_group_label>Electrode Sensor, FSE</arm_group_label>
    <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor, and/or FSE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrode Sensor, Ultrasound</arm_group_label>
    <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor, and/or Ultrasound</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Laboring women in Labor and Delivery Ward
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parturients presenting to Labor &amp; Delivery for labor at term (&gt;36 weeks completed
             gestation)

          -  Single viable fetus in cephalic presentation

          -  With FSE or IUPC for obstetric indications

        Exclusion Criteria:

          -  Multi fetal gestation

          -  Contraindication to FSE or IUPC placement

          -  Insufficient abdominal space for all required sensors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Busowski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Winnie Palmer Hospital for Women and Babies</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Winnie Palmer Hospital for Women and Babies</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2013</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2013</study_first_posted>
  <results_first_submitted>April 1, 2015</results_first_submitted>
  <results_first_submitted_qc>April 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 12, 2015</results_first_posted>
  <last_update_submitted>April 22, 2015</last_update_submitted>
  <last_update_submitted_qc>April 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultrasound</keyword>
  <keyword>FSE</keyword>
  <keyword>IUPC</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Electrode Sensor, FSE, Ultrasound</title>
          <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor, and/or FSE and Ultrasound</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Electrode Sensor, FSE, Ultrasound</title>
          <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor and/or FSE and Ultrasound</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="71"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fetal Heart Rate Interpretability</title>
        <description>The Fetal Heart Rate (or FHR) of the electrode sensor will be compared to the FHR of the ultrasound when both are compared to the FSE. Percentage of time that signals are interpretable will be compared between devices</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Electrode Sensor, FSE</title>
            <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor, and/or FSE</description>
          </group>
          <group group_id="O2">
            <title>Electrode Sensor, Ultrasound</title>
            <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor, and/or Ultrasound</description>
          </group>
        </group_list>
        <measure>
          <title>Fetal Heart Rate Interpretability</title>
          <description>The Fetal Heart Rate (or FHR) of the electrode sensor will be compared to the FHR of the ultrasound when both are compared to the FSE. Percentage of time that signals are interpretable will be compared between devices</description>
          <units>percentage of time the signals are inter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.4" spread="15.4"/>
                    <measurement group_id="O2" value="62.4" spread="26.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Electrode Sensor, FSE, Ultrasound</title>
          <description>Pregnant women between the ages of 18-50 with a single viable fetus in cephalic presentation monitored with Electrode Sensor and/or FSE and ultrasound</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Busowski, MD</name_or_title>
      <organization>Winnie Palmer Hospital for Women and Babies</organization>
      <phone>407-435-1485</phone>
      <email>john.busowski@orlandohealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

